Global Immune Repertoire Sequencing Market Size & Outlook
Global immune repertoire sequencing market, 2021-2033 (US$M)
Related Markets
Global immune repertoire sequencing market highlights
- The global immune repertoire sequencing market generated a revenue of USD 328.2 million in 2024 and is expected to reach USD 894.2 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 11.9% by 2033.
- In terms of segment, assay kits & reagents accounted for a revenue of USD 182.2 million in 2024.
- Services is the most lucrative product & service segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2033.
Global data book summary
| Market revenue in 2024 | USD 328.2 million |
| Market revenue in 2033 | USD 894.2 million |
| Growth rate | 11.9% (CAGR from 2025 to 2033) |
| Largest segment | Assay kits & reagents |
| Fastest growing segment | Services |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Assay Kits & Reagents, Services |
Other key industry trends
- In terms of revenue, the North America accounted for 41.9% of the global immune repertoire sequencing market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, China is the fastest growing regional market and is projected to reach USD 100.3 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Immune Repertoire Sequencing Market Scope
Immune Repertoire Sequencing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Celemics | View profile | 51-100 | Seoul, Seoul-t'ukpyolsi, South Korea, Asia | http://www.celemics.com |
| iRepertoire | View profile | 11-50 | Huntsville, Alabama, United States, North America | https://www.irepertoire.com/ |
| Illumina, Inc. | View profile | - | - | - |
| BGI Group | View profile | 5001-10000 | Shenzhen, Guangdong, China, Asia | https://www.genomics.cn/ |
| Creative-Biolabs | View profile | 51-100 | Shirley, New York, United States, North America | https://www.creative-biolabs.com |
| New England Biolabs | View profile | 501-1000 | Ipswich, Massachusetts, United States, North America | http://neb.com |
| Takara Bio Inc | View profile | 1793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | http://www.takara-bio.co.jp |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
Global immune repertoire sequencing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immune repertoire sequencing market will help companies and investors design strategic landscapes.
Assay kits & reagents was the largest segment with a revenue share of 55.51% in 2024. Horizon Databook has segmented the Global immune repertoire sequencing market based on instruments, assay kits & reagents, services covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Immune Repertoire Sequencing Product & Service Outlook (Revenue, USD Million, 2021-2033)
- Instruments
- Assay Kits & Reagents
- TCR kits
- BCR kits
- Others
- Services
- Global Immune Repertoire Sequencing Type Outlook (Revenue, USD Million, 2021-2033)
- Bulk immune repertoire sequencing
- Single cell immune repertoire sequencing
- Global Immune Repertoire Sequencing Application Outlook (Revenue, USD Million, 2021-2033)
- Oncology & Cancer Immunotherapy
- Autoimmune & Inflammatory Diseases
- Infectious Diseases & Vaccine Development
- Transplantation & Immune Tolerance
- Others
- Global Immune Repertoire Sequencing End Use Outlook (Revenue, USD Million, 2021-2033)
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others
Reasons to subscribe to Global immune repertoire sequencing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global immune repertoire sequencing market databook
-
Our clientele includes a mix of immune repertoire sequencing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global immune repertoire sequencing market , including forecasts for subscribers. This global databook contains high-level insights into Global immune repertoire sequencing market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global immune repertoire sequencing market size, by regions, 2021-2033 (US$M)
Top 10 countries: Immune repertoire sequencing market size, 2024 (US$M)
Global immune repertoire sequencing market share, by product & service, 2024 & 2033 (%, US$M)
Immune repertoire sequencing market: Opportunity assessment by country
Global immune repertoire sequencing market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
